ESPOSITO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.316
EU - Europa 7.446
AS - Asia 2.813
SA - Sud America 200
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 9
Totale 21.839
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.243
GB - Regno Unito 2.681
IT - Italia 1.880
SE - Svezia 976
SG - Singapore 962
CN - Cina 761
HK - Hong Kong 527
DE - Germania 492
UA - Ucraina 415
TR - Turchia 372
RU - Federazione Russa 254
FI - Finlandia 235
BR - Brasile 176
BG - Bulgaria 140
FR - Francia 114
IN - India 62
NL - Olanda 61
CA - Canada 55
LT - Lituania 47
IE - Irlanda 35
IR - Iran 35
BE - Belgio 25
EU - Europa 24
ID - Indonesia 13
ZA - Sudafrica 12
AT - Austria 11
CH - Svizzera 11
ES - Italia 11
PK - Pakistan 11
KR - Corea 10
MY - Malesia 10
AR - Argentina 8
AU - Australia 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
MA - Marocco 6
SI - Slovenia 6
VN - Vietnam 6
CZ - Repubblica Ceca 5
GR - Grecia 5
KG - Kirghizistan 5
NO - Norvegia 5
PA - Panama 5
PL - Polonia 5
PT - Portogallo 5
DZ - Algeria 4
JO - Giordania 4
JP - Giappone 4
MX - Messico 4
RS - Serbia 4
BD - Bangladesh 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
EE - Estonia 3
GE - Georgia 3
PE - Perù 3
PH - Filippine 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
CU - Cuba 2
DK - Danimarca 2
EG - Egitto 2
JM - Giamaica 2
LV - Lettonia 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
VE - Venezuela 2
ZW - Zimbabwe 2
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
SM - San Marino 1
TJ - Tagikistan 1
TM - Turkmenistan 1
Totale 21.839
Salva come PNG Salva come JPEG
Città #
Southend 2.066
Santa Clara 1.511
Fairfield 1.105
Woodbridge 1.011
Chandler 918
Jacksonville 789
Ashburn 681
Houston 664
Dearborn 572
Singapore 563
Hong Kong 526
Nyköping 514
Wilmington 471
Ann Arbor 449
Cambridge 374
Seattle 374
London 323
Beijing 286
Izmir 245
Milan 148
Princeton 147
Rome 140
Sofia 137
Eugene 135
San Diego 118
Modena 115
Des Moines 105
Helsinki 95
New York 85
Moscow 80
Hefei 75
Shanghai 59
Frankfurt am Main 58
Naples 58
Council Bluffs 39
Bologna 37
Los Angeles 37
Philadelphia 34
Bremen 33
Nanjing 33
Dublin 31
Boardman 30
Florence 30
Redwood City 29
Palermo 27
Verona 27
Bari 24
The Dalles 23
Turin 23
Brussels 22
San Mateo 22
Augusta 21
Norwalk 21
Toronto 21
Ottawa 20
Parma 19
Catania 18
Guangzhou 18
Brescia 17
Falls Church 17
Kunming 17
Fremont 14
Grafing 14
Jakarta 13
Pescara 13
São Paulo 13
Bangalore 12
Munich 12
Auburn Hills 11
Jinan 11
Padova 11
Saint Petersburg 11
Amsterdam 10
Bergamo 10
Indiana 10
Mashhad 10
Monmouth Junction 10
Mumbai 10
Hounslow 9
Kilburn 9
Paris 9
San Jose 9
Ardabil 8
Cosenza 8
Montreal 8
Nuremberg 8
Piacenza 8
Pisa 8
Treviso 8
Chiswick 7
Dallas 7
Genoa 7
Leawood 7
Saint-martin-du-tertre 7
Carpi 6
Casalecchio di Reno 6
Falkenstein 6
Kish 6
Napoli 6
Novara 6
Totale 16.045
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.390
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. 274
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 267
La clinica metabolica per il trattamento della lipodistrofia 265
Gli ascessi epatici nei pazienti sottoposi a trapianto ortotopico di fegato 250
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 236
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 235
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 227
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 226
Efficacy and safety of atazanavir in patients with end-stage liver disease. 221
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 217
Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study. 217
Brucellosis in a patient with end-stage liver disease undergoing liver transplantation: successful treatment with tigecycline. 214
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 211
Differential Dose Adjustments of Immunosuppressants after Resuming Boosted versus Unboosted HIV-Protease Inhibitors Postliver Transplant. 210
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 210
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 209
Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation. 207
Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients 203
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 203
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 202
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: An international observational study 200
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 198
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 198
Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR 198
Raltegravir and enfuvirtide as a “bridge” antiretroviral therapy in kidney-tranplanted patients with HIV infection receiving everolimus and low-dose cyclosporine: a case-control study 196
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 195
Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. 195
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 192
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation 191
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 190
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 190
Fatal cytomegalovirus necrotising enteritis in a small bowel transplantation adult recipient with low pp65 antigenaemia levels 189
Applicazione della scala di valutazione, Functional indipendence Measure (FIM), per la valutazione dei programmi di riabilitazione per pazienti affetti da AIDS Dementia Complex ospiti di una casa alloggio 185
Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy 185
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection 183
Un caso di tubercolosi post-trapianto ortotopico di fegato: limiti dell’impiego del quantiferon-TB gold nella diagnosi della infezione tubercolare latente ed attiva 180
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients 179
Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. 176
Artropodi vettori di agenti infettivi 176
Improving the appropriateness of antibiotic prescription in hospitals: a pilot study assessing the effectiveness of an infectious diseases specialist's consultation programme 174
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 174
Detectable HIV viral load is associated with metabolic syndrome 171
Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: Report of three cases 169
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 168
Age-related comorbidities in people living with HIV 168
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 167
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 165
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease 165
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 162
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006). 161
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 159
Immunophenotype of HIV plus patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system 159
Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation 156
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 155
Bloodstream infections (BSIs) in Liver Transplant Recipients: Analisys at an Italian Tertiary-Care Hospital 154
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 154
Prevalence of secondary causes of osteoporosis among HIV infected individuals 152
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study 151
Severity of lipodystrophy is associated with decreased health-related quality of life 150
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 150
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 149
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 149
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: The changes in opportunistic prophylaxis study 148
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 147
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 147
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 147
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: The CARe study 144
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 10(6) cells/I 144
Pharmacokinetic interaction between amprenavir/ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation 144
Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy 143
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 140
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 140
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 139
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 139
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 139
HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. 138
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 138
La trasmissione verticale di HIV nell’era della HAART 137
Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count grater than 500 cells 137
Relapse of HIV-related buffalo hump after liposuction 135
CD4-Guided treatment interruptions: a new possibile therapeutic strategy 134
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 134
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of quantiferon TB GOLD results in the transplant setting: A case report 133
Does lipodistrophy affect quality of life? 133
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 132
Body fat redistribution syndrome in HIV infected people is associated with good adherence to HAART 132
Validity of body image perception in women with HIV. 130
È possibile un counselling HIV su internet? 130
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 127
Determinants of erectile dysfunction changes in HIV infected men: a prospective study. 127
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 127
Studio caso-controllo sui fattori di rischio delle infezioni micotiche nei pazienti sottoposti a trapianto ortotopico di fegato (OLT) da donatore cadavere e da donatore vivente. 126
Body Image perception in HIV infected women with body fat redistribution. 124
GH response to GH-releasing hormone-arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy 124
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 123
Declining morbidity and mortality in AIDS patients of an Italian nursing home 123
Statistical agreement between metabolic syndrome ATP-III, IDF, EGIR and ACE classification in HIV-infected patients and association with body fat redistribution 123
Pathological fractures in patients with osteopenia and osteoporosis induced by antiretroviral therapy 122
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 122
Totale 18.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020380 0 0 0 0 0 0 0 0 0 0 193 187
2020/20212.617 236 78 182 255 404 230 213 288 133 280 195 123
2021/20222.286 31 374 189 246 53 85 118 177 220 134 367 292
2022/20232.854 300 261 229 240 316 467 46 288 333 55 166 153
2023/20241.739 111 139 122 176 283 151 149 199 52 60 104 193
2024/20254.597 219 94 93 387 1.230 791 461 287 658 258 119 0
Totale 22.044